BioTalentum
BioTalentum Ltd. is a Hungarian private biotechnology company founded in 2005, specializing in stem cell research and regenerative medicine, operating with 11–50 employees from Gödöllő, Hungary.
- Company typePrivate
- Founded2005
- HeadquartersGodollo, Hungary
- Headcount11–50
- GTM typeB2B
- OfferingServices
What BioTalentum does
BioTalentum Ltd. is a Hungarian for-profit biotechnology company founded in 2005 and headquartered in Gödöllő, Hungary. Per its firmographic description, the company specializes in biotechnology with a focus on stem cell research and regenerative medicine, suggesting an R&D-oriented profile rather than a commercial-stage therapeutics operation. With a headcount band of 11–50 employees, BioTalentum appears to operate as a small, specialist biotech — the kind of entity typically structured around grant-funded research, contract research services, academic collaborations, or pre-clinical pipeline development rather than large-scale product commercialization.
The company's website (biotalentum.eu) is the primary first-party source referenced; however, the available scrape of that URL returned only a loading/verification placeholder rather than substantive content, leaving product detail, technology platforms, pipeline assets, intellectual property, and commercial offerings unverified from first-party material. No management team, funding rounds, partnerships, awards, patents, customer logos, or pricing disclosures are present in the input data. The secondary news source referenced discusses the broader CRISPR gene editing market and an unrelated acquisition (Cellistic / Artisan Bio) and does not contain information about BioTalentum. Consequently, the business model — whether grant-funded, contract research, licensing, or product-based — cannot be confirmed from the supplied evidence. Investors should treat public-facing material as incomplete and prioritize direct diligence with company management before drawing conclusions about commercial traction, pipeline status, or revenue mechanics.
BioTalentum firmographics
Firmographics- Name
- BioTalentum
- Website
- https://biotalentum.eu
- Company type
- Private
- Founded year
- 2005
- Headcount range
- 11–50 employees
- Short description
- BioTalentum Ltd. is a Hungarian private biotechnology company founded in 2005, specializing in stem cell research and regenerative medicine, operating with 11–50 employees from Gödöllő, Hungary.
- Ownership category
- akta.pro rank
BioTalentum industry classification
Industry- Product category
- Regenerative Medicine and Stem Cell Research Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Biological Products, (No Disgnostic Substances) (2836), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Stem Cell–Based Regenerative Therapies (HLAAAGAA)
- akta.pro secondary industries
- Regenerative Immunology & Inflammation Modulation (pro-regenerative biologics) (HLAAAGAL), Cartilage, Bone & Musculoskeletal Regeneration (HLAAAGAH)
Keywords
Where BioTalentum is headquartered
LocationHeadquarters
- HQ city
- Godollo
- HQ country
- Hungary
- HQ region
- Europe
Markets served
BioTalentum business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure
BioTalentum product offering
Product offeringCore offering
BioTalentum Ltd. operates as a biotechnology company specializing in stem cell research and regenerative medicine. The firm develops cell-based technologies and regenerative therapies, serving research and life-sciences clients with stem cell-related expertise and laboratory services.
Product overview
Based on the provided sources, no specific product or service information is available. The website source shows only a loading/verification page, and the news source discusses general CRISPR market trends without detailing BioTalentum's product portfolio.
Differentiator
Problem solved
Functional benefit
Companies that use BioTalentum
Customer profileIdeal customer profiles1 record
BioTalentum technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
BioTalentum partnerships and signals
Strategic signalRecent moves1 record
BioTalentum competitors and assessment
Company assessmentBroad incumbents
- Lonza: Global contract development and manufacturing organization with major cell-and-gene-therapy services. Comparable to BioTalentum as an enabling organization in the cell therapy manufacturing chain, but operating at vastly larger scale across multiple modalities.
- Catalent: Large CDMO with dedicated cell therapy manufacturing capabilities. Comparable to BioTalentum as a participant in the regenerative medicine manufacturing ecosystem, though as an incumbent with broad biopharma services rather than a specialized stem cell developer.
Emerging players
- Century Therapeutics: Emerging iPSC-derived allogeneic cell therapy developer. Comparable to BioTalentum in its use of stem cell platforms for therapeutic development, though at a much more advanced and better-funded stage.
Direct peers
- Stemcell Technologies: Specialty provider of cell culture media, separation products, and instruments for stem cell research. Comparable to BioTalentum as a stem-cell-focused life-sciences organization, but operating in research tools rather than therapeutics.
- bit.bio: iPSC-derived cell therapy and cell model company combining stem cell biology with coding-based cell specification. Comparable to BioTalentum through its core reliance on stem cell / iPSC technology for therapeutic and research applications.
- Cellectis: Clinical-stage cell and gene therapy company working on allogeneic CAR-T and genome-edited cell therapies. Comparable to BioTalentum as a stem-cell-adjacent cell therapy platform developer.
- Gamida Cell: Commercial-stage cell therapy company with an approved stem-cell-derived product (Omisirge). Comparable to BioTalentum as a stem cell therapy developer with a path to commercialized regenerative medicine.
- Mesoblast: Clinical-stage regenerative medicine company developing mesenchymal lineage cell therapies. Directly comparable to BioTalentum as a stem-cell-derived therapeutics developer, but at a far more advanced commercial and clinical stage.
- Cellular Dynamics International (FUJIFILM CDI): Developer and manufacturer of iPSC-derived cell products for research, drug discovery, and cell therapy. Directly comparable to BioTalentum through its iPSC and stem cell differentiation focus.
- Pluristem Therapeutics: Develops placenta-derived, off-the-shelf cell therapies. Comparable as a stem-cell-focused regenerative medicine developer with platform-cell ambitions similar in spirit to BioTalentum's stem cell focus.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks5 records
Key highlights4 records
Customer concentration
BioTalentum social profiles
Digital presenceBioTalentum financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioTalentum leadership team
Management profileNumber of profiles
BioTalentum funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioTalentum M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioTalentum
What does BioTalentum do?
BioTalentum Ltd. operates as a biotechnology company specializing in stem cell research and regenerative medicine. The firm develops cell-based technologies and regenerative therapies, serving research and life-sciences clients with stem cell-related expertise and laboratory services.
When was BioTalentum founded?
BioTalentum was founded in 2005. It employs 11 to 50 people.
Where is BioTalentum based?
BioTalentum is headquartered in Godollo, Hungary, in the Europe region.
Who are BioTalentum's main competitors?
Broad incumbents on record are Lonza and Catalent. Century Therapeutics is listed as an emerging player. Direct peers are Stemcell Technologies, bit.bio, Cellectis, Gamida Cell, Mesoblast, Cellular Dynamics International (FUJIFILM CDI) and Pluristem Therapeutics.
Does BioTalentum have an API?
No public API is recorded for BioTalentum.
What industry is BioTalentum in?
BioTalentum's product category is Regenerative Medicine and Stem Cell Research Services. Its primary akta.pro industry code is HLAAAGAA, Stem Cell–Based Regenerative Therapies, with a secondary code of HLAAAGAL, Regenerative Immunology & Inflammation Modulation (pro-regenerative biologics). Its NAICS code is 541714 and its SIC code is 2836.